The leveraged finance and private equity communities came together on 29 January 2025 for the inaugural Leveraged Finance ...

But all that came to a halt when she discovered a raised bump on her right leg. “It was about the size of this thumbnail,” she told Ivanhoe. Doctors said it was melanoma… an often-aggressive ...

H.C. Wainwright analyst Robert Burns raised the firm’s price target on Replimune (REPL) to $21 from $17 and keeps a Buy rating on the shares.

Shares of Replimune Group, Inc. (NASDAQ: NASDAQ:REPL) surged 17% following the announcement that the U.S. Food and Drug Administration (FDA) has accepted the Biologics License Application (BLA) for ...